指南与共识关节外科

2023年美国风湿病学会与美国髋膝关节外科医师协会临床实践指南:对有症状的中重度骨关节炎或晚期有症状的继发性关节炎性骨坏死且非手术治疗无效的患者,择期髋或膝关节置换术最佳时机的推荐

2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective.
指南 / 共识 · J Arthroplasty · 2023-09-29

该指南由美国风湿病学会与美国髋膝关节外科医师协会制定,针对有症状且影像学显示中重度骨关节炎或晚期有症状的继发性关节炎性骨坏死、非手术治疗无效并选择择期全髋或全膝关节置换术的患者,提出关于最佳手术时机的循证推荐。工作组通过系统文献综述和GRADE方法对13个PICO问题形成共识,所有推荐证据质量均为低或极低。

要点

  • 有条件推荐不应延迟全关节置换术以尝试更多非手术治疗,包括物理治疗、非甾体抗炎药、助行器具和关节腔内注射。
  • 有条件推荐可延迟全关节置换术以进行尼古丁减量或戒烟。
  • 有条件推荐糖尿病患者延迟全关节置换术以改善血糖控制,但未确定具体指标或水平。

核心结论

  • 该指南针对有症状且影像学显示中重度骨关节炎或晚期有症状的继发性关节炎性骨坏死、非手术治疗无效的患者,提供关于全关节置换术最佳时机的循证推荐,以改善疼痛、功能、感染、住院和1年死亡等患者重要结局。
  • 工作组承认证据质量低,主要由于间接性,并希望未来研究能进一步细化推荐。

研究设计与样本

  • 由美国风湿病学会与美国髋膝关节外科医师协会制定,针对13个临床相关的PICO问题。
  • 经系统文献综述后,采用GRADE方法对证据质量(高、中、低或极低)进行分级,并创建证据表。
  • 投票小组包括13名医生和患者,讨论PICO问题直至就推荐的方向(支持/反对)和强度(强/有条件)达成共识。

主要发现

  • 投票小组有条件推荐反对延迟全关节置换术以进行额外的非手术治疗,包括物理治疗、非甾体抗炎药、助行器具和关节腔内注射。
  • 投票小组有条件推荐可延迟全关节置换术以进行尼古丁减量或戒烟。
  • 投票小组有条件推荐糖尿病患者延迟全关节置换术以改善血糖控制,但未确定具体指标或水平。
  • 投票小组共识认为肥胖本身不是延迟的理由,但应强烈鼓励减重,并应讨论手术风险增加。
  • 投票小组有条件推荐反对对严重畸形或骨丢失患者、或神经性关节病患者延迟手术。

关键数值与推荐

  • 所有推荐的证据质量均评为低或极低。
  • 有条件推荐反对延迟全关节置换术以进行额外的非手术治疗(包括物理治疗、非甾体抗炎药、助行器具和关节腔内注射)。
  • 有条件推荐可延迟全关节置换术以进行尼古丁减量或戒烟。
  • 有条件推荐糖尿病患者延迟全关节置换术以改善血糖控制,但未确定具体指标或水平。
  • 有条件推荐反对对严重畸形或骨丢失患者、或神经性关节病患者延迟手术。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 所有推荐的证据质量均评为低或极低。
  • 工作组承认证据质量低,主要由于间接性。
  • 工作组希望未来研究能进一步细化推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop evidence-based consensus recommendations for the optimal timing of hip and knee arthroplasty to improve patient-important outcomes including, but not limited to, pain, function, infection, hospitalization, and death at 1 year for patients with symptomatic and radiographic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis of the hip or knee who have previously attempted nonoperative therapy, and for whom nonoperative therapy was ineffective, and who have chosen to undergo elective hip or knee arthroplasty (collectively referred to as TJA). METHODS: We developed 13 clinically relevant population, intervention, comparator, outcomes (PICO) questions. After a systematic literature review, the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to rate the quality of evidence (high, moderate, low, or very low), and evidence tables were created. A Voting Panel, including 13 physicians and patients, discussed the PICO questions until consensus was achieved on the direction (for/against) and strength (strong/conditional) of the recommendations. RESULTS: The panel conditionally recommended against delaying TJA to pursue additional nonoperative treatment including physical therapy, nonsteroidal antiinflammatory drugs, ambulatory aids, and intraarticular injections. It conditionally recommended delaying TJA for nicotine reduction or cessation. The panel conditionally recommended delay for better glycemic control for patients who have diabetes mellitus, although no specific measure or level was identified. There was consensus that obesity by itself was not a reason for delay, but that weight loss should be strongly encouraged, and the increase in operative risk should be discussed. The panel conditionally recommended against delay in patients who have severe deformity or bone loss, or in patients who have a neuropathic joint. Evidence for all recommendations was graded as low or very low quality. CONCLUSION: This guideline provides evidence-based recommendations regarding the optimal timing of TJA in patients who have symptomatic and radiographic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis for whom nonoperative therapy was ineffective to improve patient-important outcomes, including pain, function, infection, hospitalization, and death at 1 year. We acknowledge that the evidence is of low quality primarily due to indirectness and hope future research will allow for further refinement of the recommendations.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hannon CP, Goodman SM, Austin MS, et al. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. J Arthroplasty. 2023. PMID: 37778918. doi:10.1016/j.arth.2023.09.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。